4 Penny Stocks Insiders Are Buying
4 Penny Stocks Insiders Are Buying
4 便士股票內部人士正在購買
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
TMC the metals company
- The Trade: TMC the metals company Inc. (NASDAQ:TMC) Director ERAS Capital LLC acquired a total of 1000000 shares at an average price of $2.09. To acquire these shares, it cost $2,090,000.00.
- What's Happening: The company's stock dropped around 80% over the past six months.
- What TMC the metals company Does: TMC The Metals Co Inc is an explorer of lower-impact battery metals from seafloor polymetallic nodules. It supplies metals for the clean energy transition with the least possible negative environmental and social impact and accelerates the transition to a circular metal economy.
Creatd
- The Trade: Creatd, Inc. (NASDAQ:CRTD) Co-CEO Jeremy Frommer acquired a total of 2676 shares at an average price of $2.24. The insider spent $6,005.35 to buy those shares.
- What's Happening: Creatd recently announced the release of 'Pledges' monetization feature.
- What Creatd Does: Creatd Inc empowers creators, brands, and entrepreneurs through technology and partnership. The company has three platforms, namely Vocal Ventures, Creatd Partners, and Recreatd.
Emmaus Life Sciences
- The Trade: Emmaus Life Sciences, Inc. (OTC:EMMA) Director James P Geiskopf acquired a total of 57291 shares at an average price of $0.29. To acquire these shares, it cost $16,499.81.
- What's Happening: The company's shares dropped 7.2% on Monday.
- What Emmaus Life Sciences Does: Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases.
MJ Holdings
- The Trade: MJ Holdings, Inc. (OTC:MJNE) Chairman & Chief Cultivation Officer Paris Balaouras acquired a total of 33393 shares at an average price of $0.30. The insider spent $9,999.88 to buy those shares.
- What's Happening: The company's stock tumbled around 14% over the past month.
- What MJ Holdings Does: MJ Holdings Inc engages in the provision of consulting and operating services to the regulated cannabis industry. It provides a full spectrum of infrastructure, construction, cultivation management, production management, distribution consulting, and operating services to cultivation and production operators.
當內部人士買賣股票時,這表明了他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易員可以在他們的整體投資或交易決策中考慮這一因素。
以下是最近幾筆值得注意的細價股內幕交易。欲瞭解更多資訊,請查看Benzinga的內幕交易平臺。
金屬公司TMC
- 行業:金屬公司TMC。(納斯達克股票代碼:TMC)董事時代資本有限公司以2.09美元的平均價格收購了總計1000000股票。收購這些股份的成本為2,090,000.00美元。
- 正在發生的事情:該公司的股票在過去六個月裡下跌了約80%。
- 這家金屬公司TMC做的是:TMC The Metals Co Inc.是一家從海底多金屬結核中開採影響較小的電池金屬的公司。它為清潔能源過渡提供金屬,盡可能減少對環境和社會的負面影響,並加速向迴圈金屬經濟的過渡。
創建
- 《貿易》:Creatd公司納斯達克(Sequoia Capital:CRTD)聯席首席執行官傑裡米·弗羅默以2.24美元的平均價格收購了總計2,676股票。這位內部人士花了6,005.35美元購買了這些股票。
- 發生了什麼事?:Creatd最近宣佈推出“質押”貨幣化功能。
- Creatd做了什麼:Creatd Inc.通過技術和合作夥伴關係賦予創作者、品牌和企業家權力。該公司有三個平臺,即Voice Ventures、Creatd Partners和Recreatd。
伊瑪烏斯生命科學
- 《貿易》:埃馬烏斯生命科學公司(場外交易代碼:EMMA)董事詹姆斯·P·蓋斯科普夫以0.29美元的平均價格收購了總計57291股票。收購這些股份的成本為16,499.81美元。
- 發生了什麼事?:該公司股價週一下跌7.2%。
- 埃瑪烏斯生命科學是做什麼的:Emmaus生命科學公司是一家生物製藥公司,主要從事罕見和孤兒疾病的新療法和療法的發現、開發和商業化。
MJ控股
- 《貿易》:MJ控股公司(場外交易代碼:MJNE)董事長兼首席種植官帕裡斯·巴勞拉斯以0.3美元的平均價格收購了總計33393股。這位內部人士花了9999.88美元購買了這些股票。
- 發生了什麼事?在過去的一個月裡,該公司的股票暴跌了約14%。
- MJ Holdings做了什麼:MJ控股公司從事向受監管的大麻行業提供諮詢和運營服務。它為種植和生產經營者提供全方位的基礎設施、建設、種植管理、生產管理、分銷諮詢和運營服務。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
搶先評論
0 0 0
讚好勁正笑哭社會社會Emm惨惨嬲嬲
輕觸選擇心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧
點擊這裡與好友分享
暫無評論,快來留言吧!